newsfilter
← Latest News
GlobeNewswire·

GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates

Engagement with FDA on GH001 IND complete response ongoingFull dataset from the Phase 2b clinical trial of GH001 in TRD reported in July 2025Long-term clinical data on safety and efficacy from Open-Label Extension